Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Reporting System Database

By Motola Domenico  

Drug Safety, Vol. 35, Iss. 4, 2012-04 ,pp. : 315-323

Adis International

Access to resources Recommend Favorite

An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System Database

By Wang Hsin-wei  

Drug Safety, Vol. 33, Iss. 12, 2010-12 ,pp. : 1117-1133

Adis International

Access to resources Recommend Favorite

`Extreme Duplication' in the US FDA Adverse Events Reporting System Database

By Hauben Manfred   Reich Lester   DeMicco James   Kim Katherine  

Drug Safety, Vol. 30, Iss. 6, 2007-01 ,pp. : 551-554

Adis International

Access to resources Recommend Favorite

Prospective Data Mining of Six Products in the US FDA Adverse Event Reporting System: Disposition of Events Identified and Impact on Product Safety Profiles

By Bailey Steven   Singh Ajay   Azadian Robert   Huber Peter   Blum Michael  

Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. : 139-146

Adis International

Access to resources Recommend Favorite

A review of the Vaccine Adverse Event Reporting System database

By Geier David A   Geier Mark R  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 691-698

Informa Healthcare

Access to resources Recommend Favorite